Identification of a Novel Mesenchymal Stem Cell-Related Signature for Predicting the Prognosis and Therapeutic Responses of Bladder Cancer
Conclusions: The five-gene MSC prognostic model demonstrates substantial efficacy in prognosticating clinical outcomes and gauging responsiveness to chemotherapy and immunotherapy regimens. The genes ZNF165, MXRA7, CEMIP, ARL4C, and CERCAM are underscored as promising candidates warranting further e...
Saved in:
Main Authors: | Enguang Yang (Author), Luhua Ji (Author), Xinyu Zhang (Author), Suoshi Jing (Author), Pan Li (Author), Hanzhang Wang (Author), Luyang Zhang (Author), Yuanfeng Zhang (Author), Li Yang (Author), Junqiang Tian (Author), Zhiping Wang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Mesenchymal Stem Cells and Exosomes in Tumor Development and Targeted Antitumor Therapies
by: Enguang Yang, et al.
Published: (2023) -
Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
by: Yao Y, et al.
Published: (2021) -
Identification of a Four-Gene Metabolic Signature to Evaluate the Prognosis of Colon Adenocarcinoma Patients
by: Yang Zheng, et al.
Published: (2022) -
An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
by: Yu Zhang, et al.
Published: (2023) -
Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer
by: Chong Shen, et al.
Published: (2023)